Sign in

CIK 0001585608

  • Non-accelerated filer
  • Smaller reporting company

Jaguar Health, Inc.

Sign in to watch
Ticker
JAGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-371-8300
Business address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Former names
Jaguar Animal Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-17 King Steven R. See Remarks Option exercise · Restricted stock units −1 0
2025-05-17 CONTE LISA A CEO and President Option exercise +2 666
2025-05-17 CONTE LISA A CEO and President Option exercise · Restricted stock units −2 0
2025-03-31 MICEK JOHN Director Purchase · Convertible Promissory Note +9,000 $50,000.00 $450.0M 9,000
2025-03-31 MICEK JOHN Director Purchase · Warrant to Purchase Common Stock +9,000 9,000
2025-03-31 King Steven R. See Remarks Purchase · Convertible Promissory Note +3,600 $20,000.00 $72.0M 3,600
2025-03-31 King Steven R. See Remarks Purchase · Warrant to Purchase Common Stock +3,600 3,600
2025-03-31 Siegel Jonathan B. Director Purchase · Convertible Promissory Note +9,000 $50,000.00 $450.0M 9,000
2025-03-31 Siegel Jonathan B. Director Purchase · Warrant to Purchase Common Stock +9,000 9,000
2025-03-31 CONTE LISA A CEO and President Purchase · Convertible Promissory Note +9,000 $50,000.00 $450.0M 9,000
2025-03-31 CONTE LISA A CEO and President Purchase · Warrant to Purchase Common Stock +9,000 9,000
2025-03-31 Chaturvedi Pravin R Chief Scientific Officer Purchase · Convertible Promissory Note +3,600 $20,000.00 $72.0M 3,600
2025-03-31 Chaturvedi Pravin R Chief Scientific Officer Purchase · Warrant to Purchase Common Stock +3,600 3,600
2025-03-31 BOCHNOWSKI JAMES J Director Purchase · Convertible Promissory Note +27,002 $150,000.00 $4.1B 27,002
2025-03-31 BOCHNOWSKI JAMES J Director Purchase · Warrant to Purchase Common Stock +27,002 27,002
2025-03-31 Wolin Jonathan S. See Remarks Purchase · Convertible Promissory Note +9,000 $50,000.00 $450.0M 9,000
2025-03-31 Wolin Jonathan S. See Remarks Purchase · Warrant to Purchase Common Stock +9,000 9,000
2025-03-31 Lizak Carol R. Chief Financial Officer Purchase · Convertible Promissory Note +5,400 $30,000.00 $162.0M 5,400
2025-03-31 Lizak Carol R. Chief Financial Officer Purchase · Warrant to Purchase Common Stock +5,400 5,400
2024-10-08 Lizak Carol R. Chief Financial Officer Grant or award +4,280 4,297

Page 3 of 10 · 185 trades